
IntelGenx Technologies
(TSX) IGX
IntelGenx Technologies Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.05M
Net Income (TTM)
$11.03M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IGX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout IntelGenx Technologies
Industry
Pharmaceuticals
Sector
Health CareEmployees
57
CEO
Dwight Gorham
Website
www.intelgenx.comHeadquarters
Montreal, QC H4S 1Y2, CA
IGX Financials
Key Financial Metrics (TTM)
Gross Margin
-67%
Operating Margin
-9%
Net Income Margin
-10%
Return on Equity
1%
Return on Capital
67%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$694.00K
Operating Income
$9.49M
EBITDA
$7.54M
Operating Cash Flow
$6.53M
Capital Expenditure
$180.00K
Free Cash Flow
$6.71M
Cash & ST Invst.
$2.28M
Total Debt
$15.50M
IntelGenx Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$174.00K
+7.4%
Gross Profit
$310.00K
+0.0%
Gross Margin
-1.78%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$4.03M
-37.7%
EBITDA
$3.03M
-25.7%
Quarterly Fundamentals
Net Cash
$15.68M
-52.3%
Accounts Receivable
$819.00K
+4.2%
Inventory
$173.00K
+147.1%
Long Term Debt
$5.40M
+0.6%
Short Term Debt
$11.06M
+26.0%
Return on Assets
-1.20%
N/A
Return on Invested Capital
67.31%
N/A
Free Cash Flow
$2.86M
-22.3%
Operating Cash Flow
$2.86M
-26.3%